Didier Barret

Keine laufenden Positionen mehr

59 Jahre

Consumer Services

Health Technology

Profil

Didier Barret worked as the President-Europe, Middle East & Africa at Mylan, Inc. and as the Regional Director-EMEA at Merck Generics from 2000 to 2007.
He holds an MBA from the University of Lyon and a doctorate from the University of Grenoble.

Ehemalige bekannte Positionen von Didier Barret

Unternehmen	Position	Ende
Merck Generics	Corporate Officer/Principal	01.01.2007
Mylan, Inc. Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA.	Corporate Officer/Principal	-

Sehen Sie sich die Erfahrung von Didier Barret im Detail an

Ausbildung von Didier Barret

University of Grenoble	Doctorate Degree
University of Lyon	Masters Business Admin

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Sehen Sie sich die Erfahrung von Didier Barret im Detail an

Beziehungen

Beziehungen ersten Grades

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Sehen Sie sich das persönliche Netzwerk an

Unternehmensverbindungen

Private Unternehmen	2
Mylan, Inc. Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA.	Health Technology
Merck Generics